Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patients.

Clinical & Developmental Immunology
Kristen M DrescherHenry T Lynch

Abstract

High levels of microsatellite instability (MSI-high) are a cardinal feature of colorectal tumors from patients with Lynch Syndrome. Other key characteristics of Lynch Syndrome are that these patients experience fewer metastases and have enhanced survival when compared to patients diagnosed with microsatellite stable (MSS) colorectal cancer. Many of the characteristics associated with Lynch Syndrome including enhanced survival are also observed in patients with sporadic MSI-high colorectal cancer. In this review we will present the current state of knowledge regarding the mechanisms that are utilized by the host to control colorectal cancer in Lynch Syndrome and why these same mechanisms fail in MSS colorectal cancers.

References

Dec 1, 1975·Cancer·M K Schwartz
Aug 1, 1975·Archives of Surgery·D MurrayL G Hampson
Dec 1, 1975·Cancer·T MutoB C Morson
Jun 1, 1992·Gut·J R Jass, S M Stewart
Mar 1, 1990·Baillière's Clinical Gastroenterology·D ShibataM Perucho
May 1, 1991·Diseases of the Colon and Rectum·H F VasenH T Lynch
Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Aug 30, 1990·The New England Journal of Medicine·R J SlebosW J Mooi
Jul 15, 1990·International Journal of Cancer. Journal International Du Cancer·H F VasenA P Heintz
Apr 24, 1987·Cell·J W KapplerP Marrack
Jun 1, 1971·Cancer·H T Lynch, A J Krush
Feb 1, 1966·Archives of Internal Medicine·H T LynchA J Krush
Jul 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H F VasenP Meera Khan
Jun 1, 1994·The American Journal of Medicine·P WatsonH T Lynch
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·N P BhattacharyyaM Meuth
Mar 18, 1994·Science·N PapadopoulosM D Adams
Jan 28, 1994·Cell·G J Nossal
May 7, 1993·Science·L A AaltonenS R Hamilton
May 7, 1993·Science·S N ThibodeauD Schaid
Dec 20, 1995·International Journal of Cancer. Journal International Du Cancer·M AarnioH J Järvinen
Nov 1, 1995·Seminars in Surgical Oncology·H T LynchJ R Jass
Mar 6, 1996·Journal of the National Cancer Institute·M S Rhyu
Feb 8, 1996·International Journal of Cancer. Journal International Du Cancer·H F VasenP Meera Khan
Feb 20, 1997·International Journal of Cancer. Journal International Du Cancer·L LosiJ Benhattar
Sep 1, 1996·The Journal of Experimental Medicine·J O'ConnellF Shanahan
Jul 17, 1997·International Journal of Cancer. Journal International Du Cancer·D W VoskuilP van't Veer
Nov 14, 1997·Nature Genetics·U RadhakrishnaS E Antonarakis
May 21, 1998·The New England Journal of Medicine·L A AaltonenA de la Chapelle
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·M L VeiglS D Markowitz

❮ Previous
Next ❯

Citations

Aug 18, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Amanda I PhippsPolly A Newcomb
Mar 23, 2011·Future Oncology·Frank A Sinicrope, Zhineng Jayson Yang
Nov 28, 2013·Annual Review of Medicine·Linghua Wang, David A Wheeler
Sep 21, 2013·Langenbeck's Archives of Surgery·Matthias KloorMagnus von Knebel Doeberitz
Nov 20, 2015·Expert Review of Gastroenterology & Hepatology·Iris N PardieckPeter J K Kuppen
Jan 10, 2012·Journal of the American College of Surgeons·Jinru ShiaDavid S Klimstra
Apr 18, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Henry T LynchKristen M Drescher
May 22, 2016·Clinical Neurology and Neurosurgery·Talia Wegman-OstroskyTeresa Corona-Vázquez
Jul 2, 2016·International Journal of Molecular Sciences·Natasja L de VriesPeter J K Kuppen
Sep 13, 2016·International Journal of Environmental Research and Public Health·Cong-Min ZhangLan Fan
Jun 22, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D Scott McMeekinPaul J Goodfellow
Feb 14, 2016·Familial Cancer·Päivi Peltomäki
Feb 14, 2016·Familial Cancer·Gaurav GoyalPeter Todd Silberstein
Aug 3, 2019·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Venkata S KatabathinaSrinivasa R Prasad
May 2, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Soyoun Rachel KimJanice S Kwon
Feb 6, 2016·International Journal of Colorectal Disease·Eline C SoerWouter H de Vos tot Nederveen Cappel
Feb 7, 2019·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Maarit AhtiainenJan Böhm
Dec 4, 2020·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Mary Garland-KledzikAnton J Bilchik
Jun 15, 2021·Current Oncology Reports·Danielle M Pastor, Jeffrey Schlom
Oct 6, 2021·Journal of Comparative Effectiveness Research·Firas BaidounOmar Abdel-Rahman

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.